Cara Therapeutics Inc (CARA) stock has fallen -85.99% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives CARA stock a score of 35 out of a possible 100.
That rank is primarily influenced by a short-term technical score of 0. CARA's rank also includes a long-term technical score of 12.
CARA has an Overall Score of 35. Find out what this means to you and get the rest of the rankings on CARA!
Cara Therapeutics Inc (CARA) stock has risen 3.06% while the S&P 500 has fallen -0.87% as of 12:51 PM on Friday, Mar 15. CARA is up $0.02 from the previous closing price of $0.79 on volume of 236,584 shares. Over the past year the S&P 500 is higher by 28.93% while CARA has fallen -85.99%. CARA lost -$2.19 per share in the over the last 12 months.
Click Here to get the full Stock Report for Cara Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
